J Pediatr Infect Dis 2014; 09(04): 183-187
DOI: 10.3233/JPI-140435
Case Report
Georg Thieme Verlag KG Stuttgart – New York

BK virus-induced severe hemorrhagic cystitis in non-transplant oncology patients: A case series

May Al Barrak
a   Pediatric Infectious Diseases Section, Children Hospital, King Fahad Medical City, Riyadh, Saudi Arabia
,
Tariq Al Fawaz
a   Pediatric Infectious Diseases Section, Children Hospital, King Fahad Medical City, Riyadh, Saudi Arabia
,
Mohammed Al Shehri
a   Pediatric Infectious Diseases Section, Children Hospital, King Fahad Medical City, Riyadh, Saudi Arabia
,
Dayel Al Shahrani
a   Pediatric Infectious Diseases Section, Children Hospital, King Fahad Medical City, Riyadh, Saudi Arabia
,
Nagi Elsiddiq
a   Pediatric Infectious Diseases Section, Children Hospital, King Fahad Medical City, Riyadh, Saudi Arabia
,
Mohamed Al Riyes
a   Pediatric Infectious Diseases Section, Children Hospital, King Fahad Medical City, Riyadh, Saudi Arabia
› Author Affiliations

Subject Editor:
Further Information

Publication History

01 October 2014

07 November 2014

Publication Date:
28 July 2015 (online)

Abstract

Hemorrhagic cystitis is often a serious condition in cancer patients and can be life threatening despite aggressive treatment measures. The condition may be secondary to infections, radiation or chemotherapy. Oxazaphosphorine alkylating agents, such as cyclophosphamide and ifosfamide, are the most frequent causes of chemotherapy-induced HC in cancer patients. Only a few cases of BK virus-associated hemorrhagic cystitis in non-transplant cancer patients have been reported worldwide. Here, we report two cases of BK-induced HC in non-transplant oncology patients; one patient died due to multi-system failure of unknown etiology, and the other patient was treated successfully with low-dose cidofovir.